oxonic acid has been researched along with Gallbladder Neoplasms in 32 studies
Oxonic Acid: Antagonist of urate oxidase.
Gallbladder Neoplasms: Tumors or cancer of the gallbladder.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a patient with gallbladder cancer and multiple liver and lymph node metastases which completely responded to S-1, an oral fluoropyrimidine anticancer drug." | 2.73 | [Unresectable gallbladder cancer with lymph node and liver metastases completely responding to S-1 monotherapy - a case report]. ( Furuse, J; Ishii, H; Nakachi, K; Shimizu, S; Suzuki, E; Yoshino, M, 2007) |
| "They include intrahepatic and extrahepatic cholangiocarcinomas, gallbladder carcinomas, and ampullary carcinomas." | 2.58 | Gemcitabine-based chemotherapy for advanced biliary tract carcinomas. ( Abdel-Rahman, O; Elhalawani, H; Elsayed, Z, 2018) |
| "In our case, we report a gallbladder cancer with portal vein thrombus." | 1.48 | Gallbladder cancer with tumor thrombus in the portal vein: A case report. ( Bai, XL; Chen, W; Liang, TB; Ma, T; Tu, JJ; Zhang, XZ, 2018) |
| "She was diagnosed with advanced gallbladder cancer that occurred concurrently with stomach cancer." | 1.46 | [A Case of an Elderly Patient Who Experienced Long-Term Survival after Receiving S-1 for Synchronous Advanced Gallbladder and Stomach Cancer]. ( Iida, S; Kurihara, N; Matsuura, Y; Tsutsui, R, 2017) |
| "GEM improved prognosis of patients with gallbladder cancer after R1/R2 resections." | 1.40 | Gemcitabine-based adjuvant chemotherapy for patients with advanced gallbladder cancer. ( Abe, T; Ensako, T; Hino, K; Nakamura, M; Nakashima, H; Yoshida, K, 2014) |
| "Gemcitabine plus S-1 was again administered as postoperative adjuvant chemotherapy." | 1.40 | Curative resection of gallbladder cancer with liver invasion and hepatic metastasis after chemotherapy with gemcitabine plus S-1: report of a case. ( Ide, T; Ide, Y; Kai, K; Kitahara, K; Koga, H; Miyoshi, A; Nakamura, H; Nakamura, J; Noshiro, H; Okumura, T, 2014) |
| "A 55-year-old man suffering from gastric cancer associated with metastases to the lymph node, gallbladder, and liver was administered chemotherapy with S-1 and cisplatin." | 1.40 | [A case of metastatic colon carcinoma following curative resection for advanced gastric cancer associated with metastases to the liver and gallbladder]. ( Akiyama, Y; Hasuike, Y; Higuchi, I; Miyamoto, M; Tanigawa, T; Yamamoto, M, 2014) |
| "Gemcitabine was administered intravenously at a dose of 1000 mg/m(2) on days 1 and 15, and repeated every 4 weeks." | 1.37 | [Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy]. ( Handa, K; Hatogai, K; Hibi, T; Higuchi, H; Iwasaki, E; Izumiya, M; Kishino, R; Maeda, N; Mizuki, A; Mukai, K; Nakazawa, A; Seki, E; Shimoyama, Y; Takaishi, H; Takita, M; Tsukada, N, 2011) |
| "He was diagnosed with double-cancer of the gallbladder and rectum." | 1.37 | [Synchronous double cancer of the gallbladder and rectum successfully treated with S-1 as second-line chemotherapy- a case report]. ( Araki, M; Hasegawa, H; Itoh, M; Kuzushita, N; Mita, E; Mitsuta, C; Nakazuru, S; Ohta, T; Ota, M; Suemura, S; Sueyoshi, Y; Tatsumi, K; Toyama, T; Yoshio, T, 2011) |
| "We herein report a case of recurrent gallbladder cancer with a remarkable tumor response to S-1 after a failure of gemcitabine (GEM) treatment." | 1.36 | [A case of recurrent gallbladder cancer with a remarkable tumor response to S-1]. ( Ajiki, T; Fujita, T; Ku, Y, 2010) |
| "Gemcitabine (GEM) was administrated for fifteen patients as the first-line chemotherapy." | 1.36 | [Evaluation of systemic chemotherapy for unresectable gallbladder carcinoma]. ( Akagi, K; Dono, K; Fujino, S; Fujita, J; Hata, T; Ikeda, K; Iwazawa, T; Kawanishi, K; Kitada, M; Kitahara, T; Miyake, M; Munakata, K; Nagai, K; Shimano, T; Shimizu, J; Takamoto, K; Watanabe, N; Yanagawa, T, 2010) |
| "We report a case of advanced gallbladder cancer for which the anticancer drug S-1 was effective." | 1.35 | Successful treatment of advanced gallbladder cancer with an anticancer drug S-1: assessment based on intratumoral gene. ( Aiba, K; Ishida, Y; Kawakami, M; Kitajima, K; Kobayashi, S; Shiba, H; Uwagawa, T; Yanaga, K, 2008) |
| "A 68-year-old man was found to have a gallbladder cancer." | 1.35 | [A case report of S-1 monotherapy responding to unresectable gallbladder cancer]. ( Kirihara, M; Nagashima, M; Ogura, T; Tahira, H; Tajima, M, 2009) |
| "Pancreas cancer or gallbladder cancer was suspected by CT, and a high tumor marker score (CA19-9 18,625 U/mL, DUPAN-II 15,000 U/ mL elevations were acknowledged)." | 1.35 | [Marked effect of combination chemotherapy with tegafur-gimeracil-oteracil potassium and gemcitabine on a suspected case of pancreas cancer or gallbladder cancer metastasis to bone: further diagnosis of disseminated carcinomatosa of bone marrow recurrence ( Aoyama, I; Arai, O; Doi, A; Hata, T; Hirao, K; Jinno, A; Katayama, S; Kikuchi, O; Kiyosuke, Y; Maeda, Y; Matsueda, K; Miyoshi, M; Mouri, H; Sakai, A; Tanabe, W; Terashima, Y; Tsuji, Y; Yamamoto, H; Yamamoto, N, 2008) |
| " Since a curative operation is impossible in this case, we started systemic chemotherapy employing S-1 combined with hepatic arterial infusion using epirubicin hydrochloride and mitomycin C." | 1.34 | [A case of unresectable advanced gallbladder cancer treated by systemic chemotherapy combined with hepatic arterial infusion]. ( Ishiguro, A; Itoh, J; Munakata, A; Munakata, M; Sakata, Y; Shitara, K; Suzuki, K; Takahata, T, 2007) |
| "We experienced a case of advanced gallbladder cancer with a remarkable response treated by oral fluoropyrimidine anticancer drug S-1 (120 mg/day on day 1 through 28 followed by a 14-day recovery period) as first-line chemotherapy." | 1.34 | [A case report of S-1 monotherapy as first-line treatment for metastatic gallbladder cancer]. ( Amano, A; Ohkawa, S; Ueno, M, 2007) |
| "Biliary stenosis was remarkably improved." | 1.32 | [A case of advanced gallbladder cancer with biliary tract stenosis which responded to TS-1 chemotherapy]. ( Kuramochi, H; Ohashi, M; Tenma, N, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (31.25) | 29.6817 |
| 2010's | 19 (59.38) | 24.3611 |
| 2020's | 3 (9.38) | 2.80 |
| Authors | Studies |
|---|---|
| Hosoda, K | 1 |
| Fukushima, K | 1 |
| Shimizu, A | 1 |
| Motoyama, H | 1 |
| Kubota, K | 1 |
| Notake, T | 1 |
| Sugenoya, S | 1 |
| Hayashi, H | 1 |
| Yasukawa, K | 1 |
| Kobayashi, R | 1 |
| Soejima, Y | 1 |
| Urahigashi, A | 1 |
| Fukunaga, H | 1 |
| Sawami, H | 1 |
| Hiraki, M | 1 |
| Sawada, G | 1 |
| Murakami, M | 1 |
| Chihara, Y | 1 |
| Yamamoto, M | 3 |
| Kimura, H | 1 |
| Morita, S | 1 |
| Seita, K | 1 |
| Ebata, T | 1 |
| Mizuno, T | 1 |
| Maeda, A | 1 |
| Yamaguchi, R | 1 |
| Kurumiya, Y | 1 |
| Sakamoto, E | 1 |
| Hiramatsu, K | 1 |
| Ando, M | 1 |
| Nagino, M | 1 |
| Itano, O | 1 |
| Takemura, Y | 1 |
| Kishida, N | 1 |
| Tamagawa, E | 1 |
| Shinozaki, H | 1 |
| Ikeda, K | 2 |
| Urakami, H | 1 |
| Ei, S | 1 |
| Hayatsu, S | 1 |
| Suzuki, K | 2 |
| Sakuragawa, T | 1 |
| Ishii, M | 1 |
| Shito, M | 1 |
| Aiura, K | 1 |
| Fujisaki, H | 1 |
| Takano, K | 1 |
| Matsui, J | 1 |
| Minagawa, T | 1 |
| Shinoda, M | 1 |
| Kitago, M | 1 |
| Abe, Y | 1 |
| Yagi, H | 1 |
| Oshima, G | 1 |
| Hori, S | 1 |
| Kitagawa, Y | 1 |
| Abdel-Rahman, O | 1 |
| Elsayed, Z | 1 |
| Elhalawani, H | 1 |
| Zhang, XZ | 1 |
| Tu, JJ | 1 |
| Chen, W | 1 |
| Ma, T | 1 |
| Bai, XL | 1 |
| Liang, TB | 1 |
| Shinmura, K | 1 |
| Kaiho, T | 1 |
| Yanagisawa, S | 1 |
| Okamoto, R | 1 |
| Nishimura, M | 1 |
| Kobayashi, S | 2 |
| Okaniwa, A | 1 |
| Tsuchiya, S | 1 |
| Shimizu, W | 1 |
| Adikrisna, R | 1 |
| Nakamura, N | 1 |
| Irie, T | 1 |
| Matsumura, S | 1 |
| Tanaka, S | 2 |
| Arii, S | 1 |
| Nakamura, M | 1 |
| Nakashima, H | 1 |
| Abe, T | 1 |
| Ensako, T | 1 |
| Yoshida, K | 1 |
| Hino, K | 1 |
| Okumura, T | 2 |
| Nakamura, J | 1 |
| Kai, K | 1 |
| Ide, Y | 1 |
| Nakamura, H | 2 |
| Koga, H | 1 |
| Ide, T | 1 |
| Miyoshi, A | 1 |
| Kitahara, K | 1 |
| Noshiro, H | 1 |
| Higuchi, I | 1 |
| Akiyama, Y | 1 |
| Tanigawa, T | 1 |
| Hasuike, Y | 1 |
| Miyamoto, M | 1 |
| Eto, R | 1 |
| Nakatsu, H | 1 |
| Ozasa, H | 1 |
| Shimizu, R | 1 |
| Hiraki, S | 1 |
| Kanesada, K | 1 |
| Harada, T | 1 |
| Tada, K | 1 |
| Fukuda, S | 1 |
| Tsutsui, R | 1 |
| Kurihara, N | 1 |
| Matsuura, Y | 1 |
| Iida, S | 1 |
| Kitajima, K | 1 |
| Shiba, H | 1 |
| Uwagawa, T | 1 |
| Ishida, Y | 1 |
| Aiba, K | 1 |
| Kawakami, M | 1 |
| Yanaga, K | 1 |
| Kirihara, M | 1 |
| Nagashima, M | 1 |
| Ogura, T | 1 |
| Tahira, H | 1 |
| Tajima, M | 1 |
| Fujita, T | 1 |
| Ajiki, T | 1 |
| Ku, Y | 1 |
| Tomizawa, K | 1 |
| Sasaki, K | 1 |
| Matsuda, M | 1 |
| Hashimoto, M | 1 |
| Udagawa, H | 1 |
| Sawada, T | 1 |
| Watanabe, G | 1 |
| Nakamoto, Y | 1 |
| Ogata, M | 1 |
| Shimizu, J | 1 |
| Dono, K | 1 |
| Fujino, S | 1 |
| Hata, T | 3 |
| Kitahara, T | 1 |
| Yanagawa, T | 1 |
| Munakata, K | 1 |
| Watanabe, N | 1 |
| Takamoto, K | 1 |
| Nagai, K | 1 |
| Miyake, M | 1 |
| Kawanishi, K | 1 |
| Fujita, J | 1 |
| Akagi, K | 1 |
| Iwazawa, T | 1 |
| Kitada, M | 1 |
| Shimano, T | 1 |
| Takita, M | 1 |
| Iwasaki, E | 1 |
| Hatogai, K | 1 |
| Kishino, R | 1 |
| Seki, E | 1 |
| Izumiya, M | 1 |
| Maeda, N | 1 |
| Nakazawa, A | 1 |
| Mizuki, A | 1 |
| Handa, K | 1 |
| Shimoyama, Y | 1 |
| Mukai, K | 1 |
| Higuchi, H | 1 |
| Takaishi, H | 1 |
| Hibi, T | 1 |
| Tsukada, N | 1 |
| Araki, M | 1 |
| Nakazuru, S | 1 |
| Itoh, M | 1 |
| Suemura, S | 1 |
| Mitsuta, C | 1 |
| Sueyoshi, Y | 1 |
| Ota, M | 1 |
| Ohta, T | 1 |
| Hasegawa, H | 1 |
| Tatsumi, K | 1 |
| Yoshio, T | 1 |
| Toyama, T | 1 |
| Kuzushita, N | 1 |
| Mita, E | 1 |
| Sanada, T | 1 |
| Baba, H | 2 |
| Wakabayashi, M | 1 |
| Kuwabara, H | 1 |
| Nakajima, K | 1 |
| Goseki, N | 1 |
| Sekine, S | 1 |
| Shimada, Y | 1 |
| Nagata, T | 1 |
| Moriyama, M | 1 |
| Omura, T | 1 |
| Watanabe, T | 1 |
| Hori, R | 1 |
| Yoshioka, I | 1 |
| Sawada, S | 1 |
| Fukuoka, J | 1 |
| Tsukada, K | 1 |
| Kuramochi, H | 1 |
| Tenma, N | 1 |
| Ohashi, M | 1 |
| Suzuki, S | 1 |
| Harada, N | 1 |
| Takeo, Y | 1 |
| Hayashi, T | 1 |
| Suzuki, M | 1 |
| Hanyu, F | 1 |
| Ishiguro, A | 1 |
| Munakata, M | 1 |
| Shitara, K | 1 |
| Takahata, T | 1 |
| Itoh, J | 1 |
| Sakata, Y | 1 |
| Munakata, A | 1 |
| Amano, A | 1 |
| Ohkawa, S | 1 |
| Ueno, M | 1 |
| Furuse, J | 1 |
| Nakachi, K | 1 |
| Suzuki, E | 1 |
| Shimizu, S | 1 |
| Ishii, H | 1 |
| Yoshino, M | 1 |
| Sakai, A | 1 |
| Tsuji, Y | 1 |
| Kikuchi, O | 1 |
| Jinno, A | 1 |
| Tanabe, W | 1 |
| Terashima, Y | 1 |
| Maeda, Y | 1 |
| Doi, A | 1 |
| Yamamoto, N | 1 |
| Aoyama, I | 1 |
| Arai, O | 1 |
| Kiyosuke, Y | 1 |
| Katayama, S | 1 |
| Hirao, K | 1 |
| Miyoshi, M | 1 |
| Mouri, H | 1 |
| Matsueda, K | 1 |
| Yamamoto, H | 1 |
| Terakura, M | 1 |
| Kaneko, M | 1 |
| Ikebe, T | 1 |
| Yoshioka, H | 1 |
| Tanaka, H | 1 |
| Nakadaira, K | 1 |
| Kurosaki, I | 1 |
| Ueki, H | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| PD-1 Antibody Plus Gemcitabine and Oxaliplatin (GEMOX) as Postoperative Adjuvant Therapy in Perihilar Cholangiocarcinoma Patients With Positively Metastatic Lymph Nodes : a Single Arm, Phase II Trial[NCT05430698] | Phase 2 | 62 participants (Anticipated) | Interventional | 2023-01-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for oxonic acid and Gallbladder Neoplasms
| Article | Year |
|---|---|
Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
Topics: Ampulla of Vater; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; B | 2018 |
[Curative resection of stage IV advanced gallbladder cancer following combined treatment with gemcitabine and CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Aorta, Abdominal; Cholecystectomy; Combined Mo | 2014 |
2 trials available for oxonic acid and Gallbladder Neoplasms
| Article | Year |
|---|---|
Phase 2 Trial of Adjuvant Chemotherapy With S - 1 for Node-Positive Biliary Tract Cancer (N-SOG 09).
Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; Chemotherapy, Adjuvant; Cho | 2020 |
[Unresectable gallbladder cancer with lymph node and liver metastases completely responding to S-1 monotherapy - a case report].
Topics: Antimetabolites, Antineoplastic; Drug Combinations; Gallbladder Neoplasms; Humans; Liver Neoplasms; | 2007 |
28 other studies available for oxonic acid and Gallbladder Neoplasms
| Article | Year |
|---|---|
Survival Outcomes of Gemcitabine Plus S-1 Adjuvant Chemotherapy after Surgical Resection for Advanced Biliary Tract Cancer.
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherap | 2021 |
[A Case of Successful Surgical Treatment for Paraaortic Lymph Nodes Recurrence of Gallbladder Cancer].
Topics: Aged; Drug Combinations; Gallbladder Neoplasms; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic | 2019 |
A prospective feasibility study of one-year administration of adjuvant S-1 therapy for resected biliary tract cancer in a multi-institutional trial (Tokyo Study Group for Biliary Cancer: TOSBIC01).
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Ampulla of Vater; Bile Duct Neoplasms; Carcino | 2020 |
Gallbladder cancer with tumor thrombus in the portal vein: A case report.
Topics: Administration, Intravenous; Antineoplastic Agents; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; D | 2018 |
[A case of effective multidisciplinary treatment for advanced gallbladder carcinoma with distant lymph node metastases].
Topics: Antineoplastic Agents; Combined Modality Therapy; Deoxycytidine; Drug Combinations; Female; Gallblad | 2013 |
Gemcitabine-based adjuvant chemotherapy for patients with advanced gallbladder cancer.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Case-Control Studies; Chemotherapy, Adjuvant; | 2014 |
Curative resection of gallbladder cancer with liver invasion and hepatic metastasis after chemotherapy with gemcitabine plus S-1: report of a case.
Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, | 2014 |
[A case of metastatic colon carcinoma following curative resection for advanced gastric cancer associated with metastases to the liver and gallbladder].
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Colonic Neoplasms; Combin | 2014 |
[A Case of Recurrent Gallbladder Cancer with a Complete Response to S-1 Alternate-Day Administration].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Female; Gallbladder Neoplasms | 2016 |
[A Case of Locally Advanced Gallbladder Cancer That Developed Early Multiple Liver Metastasis after Curative Resection, and Achieved Long-TermPartial Remission Using S-1 and Gemcitabine].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinatio | 2016 |
[A Case of an Elderly Patient Who Experienced Long-Term Survival after Receiving S-1 for Synchronous Advanced Gallbladder and Stomach Cancer].
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Drug Combinations; Fatal Outcome; Female; Gallbl | 2017 |
Successful treatment of advanced gallbladder cancer with an anticancer drug S-1: assessment based on intratumoral gene.
Topics: Antimetabolites, Antineoplastic; Dihydrouracil Dehydrogenase (NADP); Drug Combinations; Female; Fluo | 2008 |
[A case report of S-1 monotherapy responding to unresectable gallbladder cancer].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Comb | 2009 |
[A case of recurrent gallbladder cancer with a remarkable tumor response to S-1].
Topics: Aged; Drug Combinations; Fatal Outcome; Gallbladder Neoplasms; Humans; Male; Oxonic Acid; Radiograph | 2010 |
[A case report of advanced gallbladder cancer with multiple liver metastases effectively treated by concentrated therapy with S-1].
Topics: Aged; Drug Combinations; Gallbladder Neoplasms; Humans; Liver Neoplasms; Male; Neoplasm Staging; Oxo | 2010 |
[A long-term survivor treated with S-1 and gemcitabine for recurrence following an operation for advanced gall bladder cancer].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Combinations; Fatal Outcom | 2010 |
[Evaluation of systemic chemotherapy for unresectable gallbladder carcinoma].
Topics: Adult; Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Combinations; F | 2010 |
[Advanced gallbladder cancer that showed complete response to gemcitabine plus S-1 chemotherapy].
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug | 2011 |
[Synchronous double cancer of the gallbladder and rectum successfully treated with S-1 as second-line chemotherapy- a case report].
Topics: Aged; Antimetabolites, Antineoplastic; Combined Modality Therapy; Drug Combinations; Fatal Outcome; | 2011 |
[Curative resection of gallbladder cancer with simultaneous liver metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Deoxycytidine; Drug | 2011 |
Prognostic significance of aquaporins in human biliary tract carcinoma.
Topics: Aged; Aged, 80 and over; Aquaporin 1; Aquaporin 4; Aquaporin 5; Aquaporins; Bile Duct Neoplasms; Bio | 2012 |
[A case of advanced gallbladder cancer with biliary tract stenosis which responded to TS-1 chemotherapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Diseases; Cisplatin; Constriction, Pat | 2003 |
[A case of recurrent gallbladder cancer responding to combination chemotherapy of TS-1 and CDDP].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Diarrhea | 2004 |
[A case of unresectable advanced gallbladder cancer treated by systemic chemotherapy combined with hepatic arterial infusion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Combinations; Epi | 2007 |
[A case report of S-1 monotherapy as first-line treatment for metastatic gallbladder cancer].
Topics: Administration, Oral; Aged; Antimetabolites, Antineoplastic; Drug Administration Schedule; Drug Comb | 2007 |
[Marked effect of combination chemotherapy with tegafur-gimeracil-oteracil potassium and gemcitabine on a suspected case of pancreas cancer or gallbladder cancer metastasis to bone: further diagnosis of disseminated carcinomatosa of bone marrow recurrence
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Autopsy; Bone Marrow Neoplasms; Bone Neoplasms | 2008 |
[A case of unresectable advanced gallbladder cancer successfully treated by oral S-1 and hepatic arterial infusion (HAI) of low-dose CDDP therapy].
Topics: Administration, Oral; Angiography; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor | 2008 |
[Recurrent gallbladder carcinoma treated with combination chemotherapy with gemcitabine, CPT-11 and S-1--a successful case with metastatic tumors replaced by marked calcification].
Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineopla | 2008 |